Drug intelligence / Profile preview

mesenchymal stem cell

Development stage
Phase 2
Lead developer
numerous biotechnology companies worldwide
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intraarticular, Intrathecal, Intramuscular, Intramyocardial, Local Injection
01

Overview

Mesenchymal stem cells (MSCs) are multipotent stromal cells capable of differentiating into a variety of cell types, including osteoblasts (bone), chondrocytes (cartilage), and adipocytes (fat). They can be isolated from multiple tissues such as bone marrow, adipose tissue, umbilical cord blood, and placental tissue. MSCs are widely studied for their regenerative properties and immunomodulatory effects. Their mechanism of action includes homing to sites of injury or inflammation where they secrete bioactive molecules—growth factors, cytokines, extracellular vesicles—that promote tissue repair by modulating immune responses, reducing inflammation and fibrosis, stimulating angiogenesis (new blood vessel formation), and supporting the survival and proliferation of endogenous cells. Clinically investigated indications include neurological disorders (e.g., multiple sclerosis, Parkinson’s disease), autoimmune diseases, musculoskeletal injuries (e.g., osteoarthritis), diabetes complications, liver cirrhosis/fibrosis, cardiovascular diseases such as cardiac ischemia or stroke recovery. MSC therapies may use autologous or allogeneic sources; their low immunogenicity allows transplantation with minimal risk of rejection[6][8][10].

Other names
mesenchymal stromal cellMSCsmesenchymal stem cells

Beyond the preview

Go deeper on mesenchymal stem cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on mesenchymal stem cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call